00:00The FDA has approved a first-ever twice-yearly injectable regimen for HIV prevention in adults and adolescents,
00:07offering an effective alternative to daily PrEP pills.
00:10Clinical trials demonstrated nearly 100% efficacy, with nearly all participants remaining HIV-negative.
00:18While hailed as a groundbreaking step in HIV prevention, advocates and experts expressed concerns about equitable global access,
00:25especially regarding pricing and infrastructure in low- and middle-income countries.
Comments